Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
1,538,439
-
Share change
-
+972,142
-
Total reported value
-
$5,473,200
-
Price per share
-
$3.56
-
Number of holders
-
11
-
Value change
-
+$3,457,183
-
Number of buys
-
9
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q4 2021
As of 31 Dec 2021,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,538,439 shares.
The largest 10 holders included
Murchinson Ltd., Lynwood Capital Management Inc., Altium Capital Management LP, UBS Group AG, Eidelman Virant Capital, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, PVG ASSET MANAGEMENT CORP, TWO SIGMA SECURITIES, LLC, and Context Capital Management, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.